Position in RCUS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,211,281
-$275,613 QoQ
Shares Held
71,725
-37.7% QoQ
Ownership
0.056%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#85
of 230 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RCUS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Rafferty Asset Management, LLC holds $331,711,589 across 163 Biotechnology names. RCUS ranks #55 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
65,798 | $32,683,840 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
38,534 | $24,027,490 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
55,332 | $16,656,591 | |
| 4 | MRNA |
Moderna, Inc.
|
111,906 | $7,836,777 | |
| 5 | INCY |
Incyte Corp
|
44,663 | $5,062,997 | |
| 6 | APGE |
Apogee Therapeutics, Inc.
|
33,369 | $4,429,067 | |
| 7 | ORKA |
Oruka Therapeutics, Inc.
|
43,110 | $4,102,778 | |
| 8 | KYMR |
Kymera Therapeutics, Inc.
|
35,287 | $4,046,360 |
All Filings in RCUS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,211,281 | 71,725 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,486,894 | 115,134 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,214,498 | 92,929 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $947,226 | 69,649 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $803,336 | 98,690 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $881,759 | 112,326 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,156,684 | 77,682 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,287,326 | 84,194 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,458,912 | 95,792 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $6,412,912 | 339,667 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $4,801,816 | 251,404 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $5,254,108 | 292,708 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $6,095,274 | 300,112 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $7,496,494 | 410,992 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $4,033,117 | 195,025 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $5,981,248 | 228,641 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,929,119 | 155,056 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $5,098,644 | 161,554 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $5,112,089 | 126,318 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $2,870,847 | 82,330 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $2,877,780 | 104,799 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $2,566,568 | 91,402 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $380,573 | 14,660 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,205,747 | 70,347 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $391,535 | 15,826 | Shares | Sole | 2020-08-07 | |
| No filing history on record for this holder in this stock. | ||||||